期刊文献+

胃癌免疫治疗 被引量:1

下载PDF
导出
摘要 胃癌在所有癌症发病率中排第5位,死亡率排第3位,全球范围内东亚地区胃癌死亡率最高,其中男性14/10万,女性9.8/10万。大多数胃癌患者在初诊时即处于进展期或存在远处转移,此类患者需接受手术,辅助化疗或免疫治疗等综合治疗.化疗是进展期胃癌标准治疗方案,主要以5-Fu加铂类为基础.目前临床常用的一线化疗方案包括FOLF0X(5-Fu+奥沙利铂+左旋叶酸)、S0X(S1+奥沙利铂)、DCF(多西他赛+顺铂+5-Fu)、ECF/E0X(表柔比星+顺铂/奥沙利铂+5-Fu/卡涪他滨)。
出处 《消化肿瘤杂志(电子版)》 2016年第4期239-242,共4页 Journal of Digestive Oncology(Electronic Version)
  • 相关文献

参考文献2

二级参考文献21

  • 1Florian Lordick,Sylvie Lorenzen,Yasuhide Yamada,David Ilson.Optimal chemotherapy for advanced gastric cancer: is there a global consensus?[J].Gastric Cancer.2014(2) 被引量:3
  • 2Yoon-Koo Kang,Kei Muro,Min-Hee Ryu,Hirofumi Yasui,Tomohiro Nishina,Baek-Yeol Ryoo,Yukimasa Kamiya,Shiro Akinaga,Narikazu Boku.A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer[J].Investigational New Drugs.2014(2) 被引量:5
  • 3Emoto K,Sawada H,Yamada Y,et al.Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Research . 2001 被引量:2
  • 4Xiao-Heng Xu,Wei Pan,Li-Hua Kang,Hui Feng,Yan-Qiu Song.Association of annexin A2 with cancer development (Review)[J]. Oncology Reports . 2015 (5) 被引量:1
  • 5Faruk Tas,Ceren Tilgen Yasasever,Senem Karabulut,Didem Tastekin,Derya Duranyildiz.Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables[J]. Biomedicine & Pharmacotherapy . 2014 被引量:1
  • 6Marino Venerito,Gerardo Nardone,Michael Selgrad,Theodoros Rokkas,Peter Malfertheiner.SJWD14082900001281[J]. Helicobacter . 2014 被引量:1
  • 7Bridgette F Peake,Rita Nahta.Resistance to HER2-targeted therapies: a potential role for FOXM1[J]. Breast Cancer Manag. . 2014 (5) 被引量:1
  • 8Ryo Suzuki,Eiichiro Yamamoto,Masanori Nojima,Reo Maruyama,Hiro-o Yamano,Kenjiro Yoshikawa,Tomoaki Kimura,Taku Harada,Masami Ashida,Takeshi Niinuma,Akiko Sato,Katsuhiko Nosho,Hiroyuki Yamamoto,Masahiro Kai,Tamotsu Sugai,Kohzoh Imai,Hiromu Suzuki,Yasuhisa Shinomura.Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk[J]. Journal of Gastroenterology . 2014 (7) 被引量:1
  • 9Fei-Fei Kong,Zeng-Qiang Qu,Hai-Hua Yuan,Jiong-Yi Wang,Mei Zhao,Yue-Hui Guo,Jing Shi,Xiao-Di Gong,You-Long Zhu,Feng Liu,Wen-Ying Zhang,Bin Jiang.Overexpression of FOXM1 is associated with EMT and is a predictor ofpoor prognosis in non-small cell lung cancer[J]. Oncology Reports . 2014 (6) 被引量:1
  • 10Xiaoxiao Li,Ruyong Yao,Lu Yue,Wensheng Qiu,Weiwei Qi,Shihai Liu,Yasai Yao,Jun Liang.FOXM 1 mediates resistance to docetaxel in gastric cancer via up‐regulating Stathmin[J]. J. Cell. Mol. Med. . 2014 (5) 被引量:1

共引文献19

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部